Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Nash

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Physical Review Letters|April 28, 2009
Zero temperature phase diagram of the Kitaev modelCharles Nash, Denjoe O'Connor
Scandinavian Journal of Infectious Diseases|March 17, 2007
Cutaneous Salmonella infectionRajeka Lazarus, David Waghorn, Charles Nash
Annals of Surgical Oncology|October 23, 2016
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular SubtypingPat Whitworth, Peter Beitsch, Angela Mislowsky, et al.
Annals of Surgical Oncology|August 8, 2014
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, et al.
Annals of Surgical Oncology|December 31, 2015
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant ChemotherapyPaul Baron, Peter Beitsch, Danielle Boselli, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Physical Review Letters|April 28, 2009
Zero temperature phase diagram of the Kitaev modelCharles Nash, Denjoe O'Connor
Scandinavian Journal of Infectious Diseases|March 17, 2007
Cutaneous Salmonella infectionRajeka Lazarus, David Waghorn, Charles Nash
Annals of Surgical Oncology|October 23, 2016
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular SubtypingPat Whitworth, Peter Beitsch, Angela Mislowsky, et al.
Annals of Surgical Oncology|August 8, 2014
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, et al.
Annals of Surgical Oncology|December 31, 2015
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant ChemotherapyPaul Baron, Peter Beitsch, Danielle Boselli, et al.
Pageof 1